Looking for Strontium ranelate found 9 matches
|
| Open monograph to display formulary status |
BNF Category |
| |
Strontium ranelate
|
Endocrine system - Strontium renelate - 06.06.02
|
| |
Links Link to Drug Section  Link to document |
|
NICE TA160: Alendronate, etidronate, risedronate, raloxifene and strontium ranelate for the primary prevention of osteoporotic fragility fractures in postmenopausal women (06.06.02)
|
|
NICE TA161: Alendronate, etidronate, risedronate, raloxifene, strontium ranelate and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women (06.06.02)
|
|
NICE TA161: Osteoporosis - secondary prevention (including strontium ranelate) (06.06.02)
|
|
NICE TA161: Osteoporosis - secondary prevention (including strontium ranelate) (06.06.01)
|
|
TA 161: Alendronate, etidronate, risedronate, raloxifene, strontium ranelate and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women (amended) (06.06.02)
|
|
TA160: Alendronate, etidronate, risedronate, raloxifene and strontium ranelate for the primary prevention of osteoporotic fragility fractures in postmenopausal women (amended) (06.06)
|
|
TA160: Alendronate, etidronate, risedronate, raloxifene and strontium ranelate for the primary prevention of osteoporotic fragility fractures in postmenopausal women (amended) (06.06.02)
|
|
TA161: Alendronate, etidronate, risedronate, raloxifene, strontium ranelate and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women (amended) (06.06)
|
|
|
